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Organogenesis is orchestrated by cell and tissue interactions mediated by molecular signals. Identiﬁca-
tion of relevant signals, and the tissues that generate and receive them, are important goals of devel-
opmental research. Here, we demonstrate that Retinoic Acid (RA) is a critical signaling molecule im-
portant for morphogenesis of mammalian submandibular salivary glands (SMG). By examining late stage
RA deﬁcient embryos of Rdh10 mutant mice we show that SMG development requires RA in a dose-
dependent manner. Additionally, we ﬁnd that active RA signaling occurs in SMG tissues, arising earlier
than any other known marker of SMG development and persisting throughout gland morphogenesis. At
the initial bud stage of development, we ﬁnd RA production occurs in SMG mesenchyme, while RA
signaling occurs in epithelium. We also demonstrate active RA signaling occurs in glands cultured ex vivo,
and treatment with an inhibitor of RA signaling blocks growth and branching. Together these data
identify RA signaling as a direct regulator of SMG organogenesis.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Saliva lubricates the mouth, aiding in speech, swallowing and
digestion, neutralizing acids damaging to teeth, and protecting
oral tissues. In mammals saliva is produced in large part by three
salivary gland pairs-the submandibular, sublingual, and parotid-
the formation and function of which have been well described in
recent reviews (Holmberg and Hoffman, 2014; Knosp et al., 2012;
Tucker, 2007). Formation of salivary glands during embryogenesis
is an active area research, being important both to the ﬁeld of
developmental biology, and also because knowledge of organo-
genesis can serve as a paradigm for regeneration of adult organs
(reviewed in (Patel and Hoffman, 2014)).
Each salivary gland is composed of numerous sac-like acini,
where saliva is produced. These are connected to the oral cavity
via a branching network of ducts. The acini and ducts, which are
epithelial, are surrounded by nerve ﬁbers, blood vessels, ﬁbro-
blasts, and immune cells, all within the context of extracellular
matrix. Current knowledge about formation of mammalianpported by the University of
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ndell).salivary glands is based largely upon studies of organogenesis of
the SMG in mouse. Mouse mutations that cause defects in em-
bryonic formation of salivary glands have been instrumental in
identifying genes critical for gland formation. Ex vivo culture ex-
periments of explanted mouse SMG tissues have yielded in-
formation about molecules and tissue interactions that regulate
gland formation.
Development of the mouse SMG occurs as a progressive series
of events, many of which involve interactions between different
tissue types. Early in gland organogenesis, at embryonic day 10.5
(E10.5), a domain of epithelium within the developing mandible
gains the ability to induce gland formation when combined with
underlying pharyngeal arch mesenchyme (Wells et al., 2013).
Genes or molecules responsible for the instructive signal are not
known, nor have any markers of this early E10.5 pre-SMG territory
been identiﬁed. At E11.5, the epithelium thickens to form a pla-
code in the oral epithelium, a morphogenic event that coincides
with a switch in instructive capacity from the epithelium to the
mesenchyme (Wells et al., 2013). The placode epithelium subse-
quently invaginates into the underlying mesenchyme forming an
initial bud by E12.5, which then branches to become a pseu-
doglandular structure by E13.5. The epithelium continues to grow
and branch, a process dependent upon signals from the me-
senchyme (Kratochwil, 1969; Kusakabe et al., 1985; Tucker, 2007;
Wells et al., 2013), resulting in a highly branched tree-like struc-
ture of epithelial acini and ducts by E17.5. In addition to signals
Fig. 1. Deﬁcient production of RA in Rdh10trex/trex embryos impairs development of the SMG. (A) Vitamin A is converted into RA via two sequential enzymatic reactions. The ﬁrst reaction,
conversion of all-trans-Retinol (Vitamin A) to all-trans-Retinal (atRAL) is mediated within an embryo by RDH10. The ﬁrst reaction is reversible, with the opposite reaction being mediated by
DHRS3. The second reaction, the irreversible conversion of the intermediate atRAL to RA, is mediated by three aldehyde dehydrogenases, ALDH1A1, ALDH1A2, and ALDH1A3. Lack of RDH10
function results in severe RA deﬁciency and embryonic lethality usually prior to E11.5 (Sandell et al., 2007). (B–E) SMG development is impaired in Rdh10trex/trex embryos rescued to survive to
E14.5 bymaternal dietary supplementationwith aminimal dose (40 μg) of the intermediate atRAL. Frontal parafﬁn sections through SMG ofwild type andmutant embryoswere stainedwith
Hematoxylin and Eosin. SMG of 40 μg atRAL-rescued Rdh10trex/trex embryos (C and E)were substantially smaller than those of wild type littermates (B and D). Blue arrowheads indicate SMG. (F
and G) Parasympathetic SMG ganglion and nerve development occurs in Rdh10trex/trex mutant embryos. Whole mount SMG from wild type (F) and Rdh10trex/trex mutant (G) embryos from
40 μg atRAL litters were immunostained for βIII neuronal tubulin (Tubb3), to reveal neurons of the parasympathetic ganglion and nerve, and with ﬂuorescent nuclear stain Red Dot, to reveal
all nuclei. For each gland a z-stack of confocal images was collapsed to form a single projection image. White dotted lines represent outline of gland epithelium visualized based on density of
nuclear stain. Scale bars¼100 μm.
D.M. Wright et al. / Developmental Biology 407 (2015) 57–6758between epithelium and mesenchyme, there are also important
are interactions between the SMG epithelium and the sub-
mandibular parasympathetic ganglion and nerve that are critical
for development of the ganglion, and for maintaining epithelial
progenitor cells in an undifferentiated state (Knosp et al., 2015;
Knox et al., 2013, 2010).Retinoic Acid (RA) is a diffusible small hormone-like molecule
generated by a two-step enzymatic oxidation of dietary Vitamin A
(Fig. 1A) (reviewed in (Duester, 2008; Niederreither and Dolle,
2008)). Vitamin A, also known as all-trans-retinol, is ﬁrst con-
verted into the metabolic intermediate all-trans-retinal (atRAL) via
retinol dehydrogenase 10 (RDH10) (Sandell et al., 2007). The
D.M. Wright et al. / Developmental Biology 407 (2015) 57–67 59intermediate atRAL is subsequently converted into the active
product RA via enzymes of the aldehyde dehydrogenase 1A
(ALDH1A) family. The initial oxidative reaction is reversible, with
the reverse conversion of the intermediate atRAL into the pre-
cursor all-trans-retinol, being carried out by the enzyme dehy-
drogenase/reductase (SDR family) member 3 (DHRS3) (Billings
et al., 2013; Feng et al., 2010). Canonical RA signaling involves
regulation of gene expression by binding of RA as a ligand to nu-
clear receptor transcription factors known as RA receptors (RAR)
(reviewed in (Mark et al., 2009)), but RA has a diverse array of
functions in addition to canonical activity (Al Tanoury et al., 2013).
Vitamin A, through its active metabolite RA, is crucial for reg-
ulating an astonishing variety of biological process, beginning in
early embryogenesis and on through adulthood (reviewed in
(Clagett-Dame and Knutson, 2011)). During embryogenesis, RA
signaling is critical for proper development of ears, eyes, palate,
heart, lungs, kidneys, the central nervous system, and other im-
portant organs and structures, and, for some processes, the cellular
and molecular function of RA has been analyzed in depth. In
contrast, the inﬂuence of RA on salivary gland morphogenesis has
not been investigated in any detail, although some data suggests it
plays a role. Lineage analysis using a Cre driver responsive to RA
signaling indicates that salivary gland tissues experience RA sig-
naling at some stage of their development (Dollé et al., 2010).
Compound mutants with double or triple Rarmutations have been
noted to have defects of salivary gland development (Lohnes et al.,
1995, 1994). Induction of Vitamin A deﬁciency by dietary restric-
tion during the latter half of gestation in rats has also been shown
to cause defects in salivary gland development (See et al., 2008).
The fact that genetic or nutritional RA deﬁciency disrupts salivary
gland development indicates that sufﬁcient RA signaling is re-
quired for gland organogenesis. However, these studies provide no
information about whether salivary gland formation is regulated
by RA directly, or if salivary gland phenotypes result as an indirect
consequence of a requirement for RA in a different process, for
example, owing to the well-established essential role for RA in
patterning the pharyngeal arches (reviewed in (Mark et al., 2004)).
The lack of investigation of RA in salivary gland development is
likely due to the fact that RA has many essential functions early in
development, making it difﬁcult to examine the requirement for
RA in morphogenesis of tissues and organs that form during the
latter half of gestation.
In this study, using Rdh10 mutant mice, we have investigated
the role of RA in morphogenesis of the SMG. Owing to the position
of the RDH10-catalyzed oxidation within the sequence of Vitamin
A metabolic reactions, and to the reversible nature of the RDH10
catalyzed step, late stage RA deﬁcient Rdh10 / mutant embryos
may be generated by supplementing the maternal diet with the
metabolic intermediate atRAL at early stages of development
(Rhinn et al., 2011). Our analysis of atRAL supplemented Rdh10 /
embryos reveals that RA is required for development of the SMG.
Moreover, we show that growth of SMG epithelium is sensitive to
RA in a dose-dependent manner. We also demonstrate that RA
signaling is active in SMG tissues throughout the time course of
their development. Interestingly, we ﬁnd that RA signaling is
present in mandibular tissues at E10.5, prior to gland initiation, in
domains approximating the area where future SMG development
will begin. Additionally, we observe that RA signaling occurs in
ex vivo cultured tissues, and that treatment of cultured glands with
a chemical inhibitor of RA signal blocks their growth and
branching morphogenesis. Together these data identify that RA
signaling directly regulates growth and branching of SMG epi-
thelium in vivo and in vitro.2. Materials and methods
2.1. Mice
The Rdh10trex and Rdh10βgeo mutant mouse lines used in this
study have been previously described (Sandell et al., 2012, 2007).
The RARE-lacZ reporter mice used to visualize RA activity, ori-
ginally generated by Janet Rossant (Rossant et al., 1991), were
obtained from Jackson laboratories (ofﬁcial name, Tg(RARE-
Hspa1b/lacZ)12Jrt). The day of the vaginal plug was considered
E0.5. All experiments involving mice were performed in ac-
cordance with a protocol approved by the Institutional Animal
Care and Use Committee at the University of Louisville.
2.2. Maternal dietary supplementation with atRAL
For modulating the dose of RA in Rdh10trex/trex mutant embryos,
supplemental atRAL was administered in the diet of pregnant fe-
male mice by mixing a suspension of all-trans-retinal (Sigma,
R2500) with powdered mouse chow. Three different doses of
atRAL supplementation were utilized in this study: 40 μg atRAL/
gram maternal food/day from E7.5 through E11.5; 80 μg atRAL/
gram maternal food/day from E7.5 through E11.5, and 300 μg
atRAL/gram maternal food/day from E7.5 through E11.5. In each
case, supplemental atRAL was administered on gestational days
E7.5 through E11.5, replaced fresh each day, with the ﬁnal dose of
atRAL supplemented chow being removed on E12.5.
2.3. SMG ex vivo culture
SMG gland rudiments containing submandibular and sub-
lingual salivary glands were dissected from mouse embryos at
E12.5 or E13.5. Isolated SMG were cultured at the medium air/
interface on ﬁlter disks (Whatman Nucleopore, 13 mm, 0.1 μm
pore size: VWR) supported at surface of medium by gaskets made
from Syglard elastomer. Medium was DMEM/F12 with 100 U/ml
penicillin, 100 μg/ml streptomycin, 150 μg/ml Vitamin C, and
50 μg/ml transferrin. Isolated glands were cultured in a humidiﬁed
incubator at 37 °C with 5%CO2/95% air. For experimental treatment
with pan-RAR inhibitor, a stock solution of 1 mM BMS 493 (Tocris,
#3509) in DMSO was added to medium for ﬁnal concentration of
2 μM BMS 493 in culture medium. An equivalent volume of DMSO
was added to medium for control samples.
2.4. Stain for RARE-lacZ or Rdh10 geoβ reporter activity
RARE-lacZ or Rdh10βgeo reporter β-galactosidase activity was
assayed by ﬁxing whole embryo or tissue specimens in 2% Paraf-
ormaldehyde/0.2% glutaraldehyde for 45–90 min on ice. Following
ﬁxation, specimens were rinsed and incubated 30 min at room
temperature in Rinse Solution A: 5 mM EGTA/2 mMMgCl2/PBS pH
7.3 (lab mixed or purchased from Millipore). Specimens were then
rinsed and incubated 15 minutes at 37 °C in pre-warmed Rinse
Solution B: 2 mM MgCl2/0.01% Sodium deoxycholate/0.02% NP40/
PBS pH 7.3 (lab mixed or purchased from Millipore). Stain Base
solution: 0.5 mM K3Fe(CN)6/0.5 mM K4Fe(CN)6/2 mM MgCl2/0.01%
Sodium deoxycholate/0.02% NP40/PBS pH 7.3 (lab mixed or pur-
chased from Millipore), was pre-warmed to 37 °C prior to addition
of the reaction substrate X-gal. When specimens were ﬁxed,
rinsed, and ready to be stained, X-gal (Sigma-Aldrich B4252, sus-
pended at 40 mg/ml in Dimethyl Formamide) was added to Stain
Base Solution to a ﬁnal concentration of 1 mg/ml. Specimens were
incubated in stain solution overnight at 37 °C in the dark. After
staining, specimens were post-ﬁxed in 4% Paraformaldehyde
overnight at 4 °C. For section staining of RARElacZ embryos,
stained whole mount specimens were equilibrated to parafﬁn
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and embedded. After sectioning, slides were de-parafﬁnized and
counterstained brieﬂy with Nuclear Fast Red. For section staining
of Rdh10βgeo embryos, unstained embryos were embedded in OCT
compound (Tissue-TEK), cryosectioned, and stained for β-ga-
lactosidase activity. Stained sections on slides were post-ﬁxed in
4% Paraformaldehyde 1 h at room temperature, then counter-
stained brieﬂy with Nuclear Fast Red.
2.5. Immunostain
Whole mount SMG tissues were immunostained as previously
described (Sandell et al., 2014). Primary antibodies used were anti-
β-glactosidase (Abcam ab9361) 1:500, anti-E-cadherin (BD Bios-
ciences #610182) 1:50, anti-Neuronal Class III β-Tubulin (Covance,
PRB0435-P) 1:1000. Fluorescently conjugated secondary anti-
bodies Alexaﬂuor 488, AlexaFluor 546 (Invitrogen), or Dynalight
488 (Abcam) were used at 1:300. Nuclei were stained with RedDot
2 (Biotium).
2.6. Analysis of SMG epithelial volume
Confocal z-stacks were rendered with the 3D image processing
software IMARIS (Bitplane AG). Surface rendering of ﬂuorescence
signal was performed to quantitate volume enclosed by surface.3. Results
3.1. RA produced by RDH10-mediated metabolism of Vitamin A is
required for development of SMG
As part of a comprehensive characterization of the requirement
for RDH10-mediated metabolism of Vitamin A in embryonic de-
velopment we have examined the phenotype of Rdh10 / mutant
embryos at multiple stages of gestation. Analysis of SMG growth
was performed on embryos carrying the Rdh10trex mutant allele. In
order to obtain Rdh10trex/trex mutant embryos E14.5 and older, the
metabolic intermediate atRAL was supplemented to maternal food
at a dose of 40 μg atRAL/gram maternal food/day from E7.5
through E11.5, henceforth “40 μg atRAL”. This low dose of atRAL
was empirically determined to rescue a subset of embryos past the
early embryonic lethality, yet leaving embryos very RA deﬁcient.
Under these atRAL supplementation conditions Rdh10 / mutant
embryos are recovered at E14.5 at 50% the expected frequency
(Table. S1). All mutant embryos recovered under these conditions
exhibit strong RA deﬁciency phenotypes of orofacial malforma-
tions and small forelimbs.
Embryos partially rescued by maternal supplementation with
40 μg atRAL were collected at E14.5. Histological sectioning and
staining reveals that the SMG of Rdh10trex/trex are much smaller
than the SMG of wild type littermates (Fig. 1B–E). The smaller size
of the SMG in Rdh10trex/trex mutant embryos, is not an indirect
consequence of reduced head size, as overall head size is similar in
wild type and mutant embryos (Fig. 1B and C). Heterozygous
Rdh10trex/þ embryos were not distinguishable from homozygous
wild type Rdh10þ /þ . The observation that SMG development is
impaired in Rdh10trex/trex mutant embryos, which are deﬁcient in
production of RA, is consistent with previous descriptions of
mouse embryos with compound mutations in multiple RAR genes,
and in rat embryos with nutritional Vitamin A deﬁciency (Lohnes
et al., 1995, 1994; See et al., 2008). In each case RA deﬁciency
causes defects in salivary gland development. Our data ad-
ditionally demonstrate that the RA needed for SMG development
is produced by activity of RDH10.
Although the SMG of Rdh10trex/trex embryos were smaller thanwild type littermates, their morphology appeared grossly normal.
All histologically identiﬁable tissues were detected in Rdh10trex/trex
mutant SMG, including branched epithelium, surrounding me-
senchyme, and neurons. The parasympathetic ganglion and nerve
of the SMG, which is known to be important for gland develop-
ment, was evident in the Rdh10trex/trex SMG in histological sections.
However, to assess the 3-dimensional morphology of the SMG
parasympathetic ganglion and nerve in Rdh10trex/trex mutant em-
bryos, whole mount glands from 40 μg atRAL supplemented litters
were immunostained for βIII neuronal tubulin (Tubb3). Whole
mount immunostaining revealed that the submandibular para-
sympathetic nerve of Rdh10trex/trex embryos is smaller, corre-
sponding to the reduced size of the gland, but appears otherwise
morphologically normal (Fig. 1F and G). The relatively normal
morphology of the parasympathetic nerve in Rdh10trex/trex glands
suggests that failure of neurogenesis is not the primary defect in
underdevelopment of the RA deﬁcient SMG.
3.2. RA effect on SMG development is dose-dependent
We then investigated whether developmental growth of SMG
is sensitive to RA in a dose-dependent manner. To address the
issue of RA dosage, we examined embryos supplemented with two
different doses of atRAL. Because it is production of the inter-
mediate atRAL that is blocked in embryos lacking RDH10 function
(Fig. 1A), RA levels may be modulated in Rdh10trex/trexmutant em-
bryos by varying the amount of atRAL supplemented to the ma-
ternal diet. RA levels in mutant embryos can be varied from se-
verely deﬁcient up to nearly normal wild type levels. The amount
and distribution of RA signaling can be inferred by the pattern
activity of the RARE-lacZ reporter transgene, which drives ex-
pression lacZ in response to canonical RA signaling through RAR
receptors (Rossant et al., 1991).
To examine embryos with different levels of RA signaling,
pregnant females were supplemented with either 80 μg atRAL/g
food/day E7.5 through E11.5, or with 300 μg atRAL/gram food/day
E7.5 through E11.5. Because RA production is maintained in
homeostatic balance via feedback regulation (D’Aniello and Wax-
man, 2015; Sandell et al., 2012), and because of the reversible
nature of the Retinol/Retinal conversion reaction, supplementation
with atRAL at these dosage levels does not markedly disturb
normal RA signaling in wild type embryos (Fig. 2A–C). In contrast
to wild type embryos for which RA signaling remains relatively
consistent at different doses of atRAL, supplementation,
Rdh10trex/trex mutant embryos have graded levels of RA signaling
from very deﬁcient up to nearly wild type (Fig. 2D–F). Rdh10trex/trex
mutant embryos from unsupplemented litters have very little RA
signaling (Fig. 2D). In these embryos the small amount of RA ac-
tivity is localized primarily within the trunk, and is not detected
with developing orofacial tissues. Supplementation of the ma-
ternal diet with 80 μg atRAL yields Rdh10trex/trex mutant embryos
with increased RA (Fig. 2E) relative to unsupplemented embryos
(Fig. 2D), but still much lower than that of wild type littermates
(Fig. 2B). At this level, RA signaling is rescued preferentially within
the trunk of the embryo, with developing orofacial tissues re-
maining very RA deﬁcient. A more complete rescue of RA signaling
is observed at the 300 μg atRAL level. At this dose Rdh10trex/trex
mutant embryos have RA signaling in a pattern nearly indis-
tinguishable from that of wild type littermates (Fig. 2C and F).
In order to determine whether RA dose impacts developmental
growth of SMG, we quantiﬁed the growth of SMG epithelium of
Rdh10trex/trex mutant glands relative wild type littermates from
80 μg atRAL and from 300 μg atRAL supplementation litters. Em-
bryos from atRAL supplemented dams were collected at E13.5
when SMG are at the pseudoglandular stage of development. SMG
were isolated and whole mount specimens were immunostained
Fig. 2. RA impacts developmental growth of SMG in a dose-dependent manner. (A–F) Addition of different amounts of atRAL to the maternal diet yields Rdh10trex/trex mutant
embryos with different levels of RA deﬁciency. Level of RA signaling is detected in E11.5 RARE-LacZ transgenic embryos by staining for β-galactosidase activity. Supple-
mentation of the maternal diet with up to 300 μg atRAL/g food/day does not markedly perturb RA signaling in wild type embryos (B and C) relative to embryos developing
without supplementation (A). Without atRAL supplementation Rdh10trex/trex embryos have severely reduced RA signaling activity (D) relative to wild type littermates (A). At
80 μg atRAL RA signaling is partially rescued in Rdh10trex/trex mutant embryos, with RA signal being rescued preferentially in the trunk of the embryo while orofacial RA signal
remains deﬁcient (E). At 300 μg atRAL supplementation, Rdh10trex/trex mutant embryos exhibit near complete rescue of RA signaling in the trunk and craniofacial structures
(F). In these embryos RA signaling is similar in level and distribution to that of wild type littermates (C). (G–P) Size of Rdh10trex/trex SMG epithelium is smaller than wild type
littermates as measured by 3-dimensional volume of E-cadherin signal. E-cadherin signal was collected as individual optical sections of whole mount SMG from wild type
and Rdh10trex/trex embryos (G, H, L and M). For each z-stack data set, an epithelial volume was computationally rendered as a surface, either by automated signal detection (I–
J), or manually (N–O), using IMARIS image analysis software. At the 80 μg supplementation dose the epithelium of Rdh10trex/trex mutant SMG are 40% the volume of their wild
type littermates (K). At the 300 μg supplementation dose the epithelium of Rdh10trex/trex mutant SMG are 70% the volume of their wild type littermates (P). For each
condition n¼3 litters, 1 gland/litter. Black scale bar is 1 mm (A–F). White scale bars are 40 μm (G, H, L and M).
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then cleared and imaged by confocal microscopy (Fig. 2G, H, L and
M). Z-stacks of optical sections were collected through the entire
gland epithelium. E-cadherin signal was then computationally
rendered as surface volume using IMARIS image analysis software
in order to assess the amount of gland epithelium in each speci-
men (Fig. 2I, J, N and O). For calculation of epithelial volume pri-
mary ducts were included at a uniform length of 40 μm.
Analysis of SMG epithelial volume from embryos rescued with
80 μg atRAL reveals that glands from Rdh10trex/trex mutant embryos
are reproducibly underdeveloped relative to the glands of wild
type littermates. With 80 μg atRAL, Rdh10trex/trex SMG were ap-
proximately 40% the size of wild type littermates (Fig. 2K). The
volume analysis reveals that, in addition to smaller size, mutant
SMG have less branching morphogenesis. SMG from wild type
embryos were branched with an average of four distinct end buds,
as expected for the E13.5 pseudoglandular stage of development.
In contrast, the corresponding SMG from Rdh10trex/trex embryos
had only a single endbud.
Increased rescue of RA signaling resulted in improved growth
and development of gland epithelium. At the 300 μg level of
atRAL supplementation the epithelium of Rdh10trex/trex mutant
SMG was approximately 70% that of wild type littermates
(Fig. 2P). In addition to the better rescue of epithelial volume,
the higher level of atRAL supplementation resulted in improved
rescue of branching morphogenesis. Rdh10trex/trex mutant SMG
from 300 μg atRAL litters had more branches than those of the
lower 80 μg atRAL rescue litters (Fig. 2O), although the branches
were not as elongated as those of wild type SMG (Fig. 2N) and
clefts between branches were not as deep. Taken together, these
data demonstrate that the inﬂuence of RA on SMG development
is dose-dependent.3.3. RA signaling in SMG tissues begins prior to initiation and con-
tinues throughout development
The observation that RA deﬁciency impairs SMG development
prompted us to examine whether RA signaling was active in SMG
tissues over the time course of development of the glands. Wild
type embryos carrying the RARE-lacZ reporter were collected at
multiple stages of gestation, prior to, and over the time course of,
SMG morphogenesis. Glands or mandible tissues were isolated
from embryos from E9.5 to E16.5 and were stained for β-ga-
lactosidase activity to identify the location of active RA signaling.
Analysis of RARE-lacZ activity at multiple gestational ages re-
veals that RA signaling activity is present in developing SMG tis-
sues throughout morphogenesis of the glands (Fig. 3A–E). Robust
RA signaling is clearly evident within isolated glands at E13.5
(Fig. 3D), corresponding to pseudo-glandular SMG that have begun
branching morphogenesis. At this stage strong β-galactosidase
activity is apparent within the gland epithelium. Scattered cells
positive for RA signal are detected also within the surrounding
mesenchyme. Analysis of mandibles isolated from earlier stage
embryos reveals that RA signaling is present at E12.5 (Fig. 3C), the
stage when SMG initial bud formation has occurred by invagina-
tion of the oral epithelium into the underlying mesenchyme. At
this stage RA signaling is observed within developing mandibles in
two domains corresponding to the locations of SMG initial buds,
one on each side of the base of the tongue.
Looking at earlier stages of development, we observe RA sig-
naling in the mandible at E11.5 (Fig. 3B), the stage when SMG
development can ﬁrst be detected morphologically as a thickening
of the oral epithelium on each side of the future base of tongue. At
this stage we observe RA signaling on the interior face of the de-
veloping mandible as two domains corresponding to two sites of
Fig. 3. RA signaling activity is present in SMG tissues throughout development of the gland. RARE-lacZ reporter signal reveals active RA signaling in embryo tissues. (A–E)
Staining for β-galactosidase activity reveals RA signaling is present throughout SMG development. (A) Two domains of active RA signaling are present on the interior region
of the developing mandible at E10.5. (B) At E11.5, as the tongue begins to elevate on the interior surface of the mandible, a domain of active RA signal is visible on either side
of the base of the tongue. (C) At E12.5, strong RA signal is visible at the base of the tongue in the position where the SMG initial buds have formed. (D) At E13.5, strong RA
signal is visible in an isolated gland. (E) RA signaling can be detected in isolated SMG at E16.5. (F and G) Frontal parafﬁn section of stained mandibles reveals that RA signaling
in E10.5 (F) and E11.5 (G) mandibles occurs within epithelial and mesenchymal tissues. (H) Immunostaining whole mount E13.5 SMG for β-galactosidase protein demon-
strates RA signaling is present within individual cells of gland epithelium. (I and J) Domains of RA signaling in E11.5 mandibles of Rdh10trex/trex mutant embryos are
modulated by atRAL supplementation. With 80 μg atRAL supplementation, mandibles of Rdh10trex/trex mutant embryos lack RA signaling (I). With 300 μg atRAL supple-
mentation, RA signaling in mandibular domains is partially rescued (J). Wild type controls corresponding to (I and J) are shown in Supplemental Fig. S1. Black scale bars,
white scale bars¼500 μm. Yellow scale bar¼100 μm, Black arrowheads point to mandibular domains of active RA signal. LE, lateral edge of oral cavity; PA1, pharyngeal arch
1; PA2, pharyngeal arch 2; T, tongue.
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the oral cavity at this stage. A previous study using a Cre driver
responsive to RA has shown that, at E12.5, RA signaling at the
lateral edges of the oral cavity lineage marks a domain of cells that
partially overlaps with the lateral edges of molar tooth buds (Dollé
et al., 2010).
In order to determine the earliest onset of RA signaling activity
in presumptive SMG tissues we examined RARE-lacZ expression in
developing mandibles at E9.5 and E10.5, prior to any overt mor-
phological development of the SMG. At E9.5, no RA signaling is
detected in the mandible (not shown). At E10.5, two domains of
RA signal become visible on the interior surface of the future
mandible (Fig. 3A). The two RA signaling domains at E10.5 en-
compass a region of pharyngeal arch 1, pharyngeal arch 2, and the
pouch between them on the inner surface of the developing
mandible. Analysis of frontal sections through the RARE-lacZ po-
sitive regions of E10.5 and E11.5 mandibles indicates that the RA
signaling domains at E10.5 and E11.5 include both epithelial and
mesenchymal tissues (Fig. 3F and G). The two RA positive domains
observed at E10.5 appear to correspond to those detected later at
E11.5 and E12.5, although the developmental relationship between
the E10.5 domains and those of later stages can only be demon-
strated cell lineage analysis.
In addition to marking early developing SMG tissues, RA sig-
naling persists later in SMG morphogenesis as well. At E16.5
scattered cells positive for RA signaling are detected within iso-
lated glands (Fig. 3E). At this canalicular/terminal bud stage of
SMG development, a smaller fraction of cells are positive for RAsignaling, suggesting that the peak of RA signaling occurs at earlier
stages of development.
Enzymatic staining for β-galactosidase to detect RARE-lacZ
transgene activity is an extremely sensitive assay for canonical RA
signaling. However, ﬂuorescent immunostaining for β-galactosi-
dase protein and imaging by confocal microscopy can yield a more
accurate picture of the distribution of cells with RA signaling. In
order to precisely deﬁne the identity and location of cells with
active RA signaling we co-immunostained E13.5 whole mount
SMG for β-galactosidase protein, to visualize RA signaling, along
with E-cadherin, to visualize gland epithelium. Confocal imaging
of immunostained glands revealed that RA signaling occurs in a
mosaic pattern in scattered cells of the epithelium of pseu-
doglandular SMG (Fig. 3H). Cells positive for β-galactosidase are
present in the branching endbuds, and in the primary duct. Scat-
tered cells positive for β-galactosidase are also present within the
gland mesenchyme, particularly within a region that appears as a
“collar” around the primary duct.
We also assessed the level and distribution of RA signaling in
mandibular tissues of Rdh10trex/trex embryos rescued at different
levels of atRAL supplementation. Rdh10trex/trex and wild type lit-
termate embryos carrying the RARE-lacZ transgene were rescued
by maternal dietary supplementation of atRAL as described pre-
viously. Embryos were collected at E11.5 and mandibles stained for
RA activity. At 80 μg atRAL, the E11.5 Rdh10trex/trex mandible has no
evidence of RA signal (Fig. 3I). At 300 μg atRAL two domains of RA
signaling were detected in the Rdh10trex/trex mandible (Fig. 3J). RA
signaling was detected wild type littermates at each dose
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tected in Rdh10trex/trex mandibles is consistent with that observed
for whole embryos. In each case 80 μg atRAL treatment provides
only poor rescue of RA signaling to orofacial tissues, while 300 μg
atRAL provides a more complete rescue.
3.4. Initiation of SMG development in unsupplemented Rdh10 /
embryos
The presence of RA signaling in the region of SMG initiation in
E11.5 embryos, and in E10.5 mandibles preceding SMG formation,
suggests the possibility that RA signaling may be critical for pro-
moting the initiation of SMG development. Our dose analysis ex-
periment demonstrates that development of SMG initiates in
embryos supplemented with atRAL. However, it is possible that
the initiation of gland growth observed in supplemented embryos
occurred because the supplemental atRAL yielded sufﬁcient RA
signal for initiation. We therefore investigated whether initiation
of SMG development occurs in Rdh10trex/trex mutant embryos not
supplemented with atRAL.
Without supplementation, most Rdh10 / mutant embryos die
prior to E11.5 or E12.5 (Rhinn et al., 2011; Sandell et al., 2012, 2007).
However, the phenotype of Rdh10/ mutant embryos is variable,
and E12.5 embryos can be recovered at low frequency in the absence
of atRAL supplementation. Histological examination of a rare un-
supplemented E12.5 Rdh10trex/trex mutant embryo reveals evidence of
initiation of SMG development (Fig. 4A and B). At the base of the
tongue the oral epithelium is clearly invaginated into the underlying
mesenchyme. The epithelial invagination appears abnormal, lacking
a distinct bulbous endbud and primary duct. The presence of an
epithelial invagination in an unsupplemented mutant embryo sug-
gests that RA signaling is not necessary for initiation of SMG devel-
opment. However, the interpretation must be made with great cau-
tion, as it is possible that a rare surviving E12.5 Rdh10trex/trex mutant
embryo is an outlier in terms of RA deﬁciency, and that the RA status
of the embryo that enabled survival to E12.5 was, likewise, sufﬁcient
to promote SMG initiation.
3.5. RA production occurs in mesenchyme but RA signaling occurs
primarily in epithelium of initial bud
We next sought to deﬁne the speciﬁc locations of RA produc-
tion and the resulting distribution of RA signaling activity within
developing SMG. To visualize the expression pattern of Rdh10,
which is the major enzyme responsible for the initial step of me-
tabolism Vitamin A into atRAL, we utilized Rdh10βgeo, a lacZ knock-Fig. 4. SMG initiation occurs in uncommon Rdh10 / embryos surviving to E12.5 witho
embryos survive past E11.5. Rare example of surviving E12.5 Rdh10 / mutant embryo h
E12.5 stage of development is an initial bud with open primary duct lumen connecting
(B) SMG of mutant embryo appears as a thick dense epithelial invagination into the mes
“duct”. M, Meckel’s cartilage; T, tongue; blue arrowheads indicate terminal endbud, orout reporter allele of Rdh10 (Sandell et al., 2012). Heterozygous
Rdh10βgeo/þ embryos, which are phenotypically wild type, were
examined at E12.5 by staining frozen sections for β-galactosidase
activity. The staining pattern of Rdh10βgeo reporter at E12.5 re-
vealed that Rdh10 is expressed exclusively within the gland me-
senchyme at the initial bud stage of development (Fig. 5A). No
signal was detected within the gland epithelium. These data in-
dicate that the ﬁrst step of RA production in the initial bud SMG
occurs within the mesenchyme.
In order to compare the tissue localization of RA signaling with
that of RA production we evaluated the distribution of RA signal-
ing in E12.5 initial bud SMG using the RARE-lacZ reporter trans-
gene. Whole mount specimens consisting of E12.5 tongue and
associated SMG were stained for β-galactosidase activity followed
by parafﬁn sectioning. RARE-lacZ reporter activity indicates that
RA signaling occurs very robustly and almost exclusively within
the epithelium of the E12.5 initial bud SMG (Fig. 5 B). In addition
to the RA activity within the epithelium, a few scattered RARE-lacZ
positive cells are also detected within the surrounding mesench-
yme. Interestingly, the RA signaling activity in gland epithelium is
speciﬁc for the SMG and is not detected within the epithelium of
the adjacent sublingual gland. Taken together these data reveal
that RA production occurs within the mesenchymal cells of the
initial bud SMG, but RA activity occurs primarily within the epi-
thelial cells.
3.6. RA signaling persists in SMG cultured ex vivo
The data presented above demonstrate that RA is required for
developmental growth of the SMG. However, the fact that many
laboratories have successfully cultured SMG ex vivo without added
RA or serum raises the possibility that RA is not essential for SMG
growth. We sought to reconcile our observations, that RA is nee-
ded for SMG development in vivo, with the ex vivo experimental
model wherein SMG can be grown in medium lacking Vitamin A
or RA. Because SMG freshly isolated from an embryo have robust
RA signaling (Fig. 3D), we postulated that retinoids and RA sig-
naling might be present in gland tissues cultured ex vivo despite
the absence of RA in the medium. To investigate whether RA sig-
naling persists in cultured glands we examined expression of the
RARE-lacZ transgene in SMG cultured on medium with no added
RA or serum. At the start of culture freshly isolated E13.5 SMG
exhibit robust RA activity (Fig. 6A). After 48 h in culture RA sig-
naling can still be detected, occurring in scattered individual cells
throughout the gland (Fig. 6B). At this stage RA signal appears to
coincide with epithelial tissue of the gland (Fig. 6B and B'). Afterut atRAL supplementation. In the absence of atRAL supplementation few Rdh10 /
as evidence of initiation of SMG morphogenesis. (A) SMG of wild type embryo at the
to the oral surface. Initial bulbous endbud is distinctly wider than primary duct.
enchyme. Primary “duct” has no lumen, “endbud” is approximately same width as
endbud-like region, of SMG epithelial invagination.
Fig. 5. RA production occurs in mesenchyme but RA signaling activity occurs in epithelium at initial bud stage. (A) Expression of Rdh10, indicated by Rdh10βgeo reporter
activity, occurs in SMG mesenchyme at E12.5. Frozen sections were stained for β-galactosidase and lightly counterstained with nuclear fast red. (B) RA signaling activity,
indicated by RARE-lacZ reporter, occurs primarily in SMG epithelium. A few scattered cells of mesenchyme are also positive for RA signaling, but sublingual gland epithelium
is negative. Whole mount mandibles were stained for β-galactosidase, parafﬁn sectioned, and lightly counterstained with nuclear fast red. Scale bar¼200 μm. Me, Meckel’s
cartilage; SL, sublingual gland; T, tongue.
Fig. 6. RA signaling occurs in SMG tissues in ex vivo culture. RARE-lacZ staining reveals active RA signaling in cultured SMG tissues. E13.5 SMG cultured 0–5 days ex vivo. (A and
A') When E13.5 SMG are initially isolated and placed in a culture dish, RA signaling is clearly evident, particularly in the area corresponding to epithelium. (A') Outline of
epithelium and mesenchyme. (B) RA signaling persists in E13.5 SMG cultured for 48 hours. (B') Gland shown in (B) imaged prior to staining allows visualization of epithelium.
(C) RA signaling remains in E13.5 SMG cultured for 3 days. (C') Gland shown in (C) imaged prior to staining allows visualization of epithelium. (D) RA signaling remains in E13.5
SMG cultured for 5 days. (D') Gland shown in (D) imaged prior to staining allows visualization of epithelium. Yellow arrows indicate position of non-epithelial tissue sur-
rounding main duct. Scale bars¼200 μm.
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detectable (Fig. 6C). At the 3 day stage, RA signal appears to co-
incide with the location of non-epithelial tissues surrounding the
main duct (Fig. 6 C and C').
One caveat to lacZ stain analyses is that β-galactosidase protein
is known to be very stable, with a half-life estimated at 24–48 h
(Gonda et al., 1989; McCutcheon et al., 2010). Thus, over a 2 or
3 day time period, which is the standard duration of SMG culture
experiments, β-galactosidase staining activity could potentially
result, not from active RA signaling in the cultured specimens, but
from residual β-galactosidase that was produced within the ani-
mal prior to culture. In order to discern if the RARE-lacZ β-ga-
lactosidase detected in cultured SMG indicates active RA signaling,
we assayed RARE-lacZ activity from SMG that were cultured for
5 days, a duration substantially longer than the half-life of β-galactosidase. Surprisingly, strong RA signaling is clearly evident in
SMG cultured for 5 days ex vivo (Fig. 6D) Again, as at the 3 day
stage, the distribution of RA signal appears to coincide with the
location of non-epithelial tissues surrounding the main duct (Fig. 6
D and D’). These data demonstrate that retinoids present within
the freshly isolated tissue persist in cultured glands and contribute
to active RA signaling despite the lack of Vitamin A or RA in the
medium.
3.7. RA signaling regulates growth and branching of ex vivo cultured
SMG
Having established that active RA signaling occurs in ex vivo
cultured SMG, we next investigated whether the RA signaling in
cultured gland tissues is relevant to their growth. To that end we
Fig. 7. Treatment with the RAR inhibitor BMS 493 disrupts growth and branching morphogenesis in ex vivo cultured SMG. (A and B) Transmitted light images of two SMG
isolated from a single embryo at E13.5 cultured ex vivo for 48 h. SMG cultured on medium containing 2 μM BMS 493 (B) had less epithelial growth with fewer branches and
endbuds relative to the contralateral gland grown on control medium (A). (C and D) SMG isolated at E13.0 and cultured ex vivo for 48 h and stained with E-cadherin to reveal
epithelium. BMS 493 –treated glands had fewer endbuds and shallower clefts (D) than contralateral gland grown on control medium (C). (E) Quantitation of branching
morphogenesis by counting endbuds of E13.5 SMG cultured 48 h. SMG grown on control medium had an average of 29 endbuds. Contralateral glands grown on medium
containing BMS 493 had an average of 3 endbuds. N¼10 gland pairs. Error bars¼Standard Deviation. Black scale bars¼200 μm, white scale bars¼50 μm.
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pan-RAR inhibitor BMS 493. SMG were isolated from E13.0–E13.5
embryos. Right and left glands from individual embryos were
cultured as matched pairs, one on medium containing 2 μM BMS
493, the other on control on medium containing vehicle (DMSO).
Glands were cultured for 72 h with daily changes of medium.
After 48 h in culture, the epithelial growth and branching
morphology SMG grown on BMS 493-containing medium was
clearly impaired relative to contralateral glands grown on control
medium (Fig. 7A and B). Glands grown on control medium had
substantially more epithelium with more branches and endbuds
than BMS 493-treated glands. After 48 h culture, control glands
had an average of 29 endbuds, while BMS 493-treated glands had
an average of 3 endbuds (Fig. 7E). The impaired growth and
branching morphogenesis of glands cultured with BMS 493 was
clearly evident following immunostain for E-cadherin (Fig. 7C and
D). BMS 493-treated glands had shallower clefts and fewer bran-
ches and endbuds than controls. The endbuds of BMS-treated
glands were fewer in number, but larger in size. Similar differences
in growth and branching morphogenesis of BMS 493 treated SMG
and controls were visible at the 24 h time point, and following
72 h of culture. The abnormal growth of SMG cultured in the
presence of the pan-RAR inhibitor BMS 493 demonstrates that the
RA signaling persisting in ex vivo cultured glands is relevant for
their growth. Moreover, because perturbation of RA signaling
impacts growth of isolated glands, the data reveal that RA sig-
naling impacts gland growth directly and not merely as an indirect
consequence of mandibular patterning.4. Discussion
RA signaling is one of the key pathways that regulate many
aspects of embryonic development. Despite the importance of RA,
and the need for understanding salivary gland biology, the role of
RA signaling in salivary gland morphogenesis has largely been
overlooked.
In this study we demonstrate that RA signaling is a critical
pathway important for embryonic organogenesis of the SMG. We
show that RA signaling is active within developing SMG tissuesfrom E11.5–E16.5 (Fig. 3B–E), and that RA signal marks two domains
within the developing mandible as early as E10.5, prior to any overt
morphogenesis of the gland (Fig. 3A). We also show that SMG de-
velopment is impaired in Rdh10-/- mutant embryos (Fig. 1B–E), de-
monstrating not only that RA is required for SMG development
in vivo, but also that the RA necessary for SMG development is
produced by the activity of RDH10. By examining Rdh10 / mutant
embryos supplemented with different doses of the metabolic in-
termediate atRAL, we demonstrate that developmental growth of
SMG in vivo is inﬂuenced by RA in a dose-dependent manner
(Fig. 2A–P). By comparing the activity of reporters of Rdh10 ex-
pression versus RA signaling we show that the ﬁrst step of RA
production occurs within initial bud mesenchyme, while the re-
sulting RA signaling occurs within the epithelium (Fig. 5A and B).
We demonstrate that SMG grown in culture have active RA sig-
naling, persistent from an in vivo source (Fig. 6A–E), and show that
treatment of cultured glands with the RAR inhibitor BMS 493 im-
pairs epithelial growth and branching morphogenesis (Fig. 7A–E).
These ﬁndings demonstrate that production of RA by RDH10-
mediated metabolism of Vitamin A regulates SMG development
during embryogenesis and does so by direct action on gland tissues.
Previous studies have suggested that salivary gland morpho-
genesis is regulated by RA. Although no salivary gland phenotype
has been reported for single Rar mutations, mice with compound
double or triple Rar mutations have been noted to have defects of
salivary gland development (Lohnes et al., 1995, 1994). Rat em-
bryos developing with late stage nutritional Vitamin A deﬁciency
exhibit defects in salivary gland development (See et al., 2008). In
humans, exposure to excessive RA in utero has been associated
with salivary gland aplasia (Adam et al., 2007). These observations
indicate that salivary gland development is disrupted if RA sig-
naling is insufﬁcient or excessive. However, they do not reveal
whether RA signaling regulates embryonic gland tissues directly,
or if the inﬂuence of RA is indirect, for example, owing to its well-
established role in patterning the pharyngeal arches (reviewed in
(Mark et al., 2004)). Our data demonstrate that properly regulated
RA signaling is necessary for SMG morphogenesis, and that RA is
produced in, and acts upon, SMG tissues directly.
The presence and distribution of active RA signaling within de-
veloping salivary glands has not been previously examined in any
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shows strong labeling of epithelium of an unspeciﬁed salivary gland at
E17.5, indicating that RA signaling was active in salivary epithelium at,
or prior to, E17.5 (Dollé et al., 2010). Several genes involved in RA
production or RA signaling, including Rdh10, Aldh1a family members,
and Rar family members, have been shown to be expressed in salivary
gland tissues at E14.5 (Dolle et al., 1990; Visel et al., 2004). However,
our study is the ﬁrst to demonstrate that active RA signaling in SMG
tissues begins much earlier and continues over the time course of
gland development. We document that RA signaling occurs in two
domains of the mandible at E10.5, beginning as two small patches that
appear to overlap with, or correspond to, the areawhere the bilaterally
paired SMG will subsequently develop. RA signal increases through
the initial bud stage at E12.5, peaking at the pseudoglandular stage of
development at E13.5, and then persists in dispersed cells through at
least the E16.5 stage of gland development. The pattern of reporter
staining indicates that RA signaling is present and active during SMG
initiation, as well as during early epithelial growth, and branching
morphogenesis. The presence of RA signaling at E10.5 in the area of
the mandible near or overlapping where the SMG will subsequently
develop is particularly intriguing, as the E10.5 stage is when the
mandibular epithelium gains the capacity to induce gland formation in
combination with non-gland mesenchyme (Wells et al., 2013). Despite
the developmental importance of this early event, no other molecule
has been identiﬁed that marks or overlaps with the future SMG do-
main at this early stage.
Development of SMG involves dynamic interactions between
epithelium and mesenchyme (Kratochwil, 1969; Kusakabe et al.,
1985; Tucker, 2007; Wells et al., 2013). Our observation that the
E12.5 SMG mesenchyme expresses Rdh10, while SMG epithelium
at that stage experiences active RA signaling (Fig. 5A and B) sug-
gests that diffusion of the metabolic product RA or the inter-
mediate atRAL away from the site of synthesis in the mesenchyme
into the adjacent epithelium may be one means of interaction
between these two tissue types.
Ex vivo organ culture of SMG has been extensively used as an
experimental model system for the study of SMG organogenesis.
Our data demonstrate that, somewhat surprisingly, RA signaling is
active in cultured glands despite the lack of Vitamin A or RAwithin
the culture medium (Fig. 6A–D). Although the scattered RA-posi-
tive cells observed in cultured glands have a distribution that is
reminiscent of the pattern seen in freshly isolated glands from
corresponding staged embryos (Figs. 6C and 3E), we do not know
if the RA is present the cultured glands accurately reﬂects the RA
signaling pattern that occurs in vivo. In vivo, disturbances of RA
signaling levels are buffered by feedback regulation of RA pro-
duction, RA signaling, and RA degradation, and can yield para-
doxical consequences in RA regulation (D’Aniello et al., 2013;
D’Aniello and Waxman, 2015; Lee et al., 2012; Sandell et al., 2012).
Thus, it is possible that cultured glands, lacking the Vitamin A
precursor normally available in circulating serum, experience
feedback regulatory changes in RA homeostasis relative to glands
in vivo, possibly increasing transcription of RAR receptors or de-
creasing transcription of RA degrading enzymes. Similarly, owing
to the feedback mechanisms that mediate homeostatic regulation
of RA signaling, the effect of treatment with RAR inhibitor may be
more complex than a simple block of RA signaling. Nonetheless,
our observation that treatment with BMS 493 impairs growth of
glands in culture demonstrates a direct link between RA signaling
and gland morphogenesis (Fig. 7A–D).
Our study demonstrates that Vitamin A metabolism and RA
signaling are critical for embryonic development of the SMG.
However, the importance of RA in salivary gland biology is likely
not limited to their developmental growth in the embryo. RA may
play a role in post-natal salivary gland maintenance and re-
generation as well. Studies of salivary gland function in rat indicatethat Vitamin A metabolism/RA production are relevant to salivary
gland health and function after birth (Anzano et al., 1981; Anzano
et al., 1980; Horn et al., 1996; Johansson et al., 1989; Trowbridge,
1969). Radiation-induced salivary gland damage is exacerbated by
Vitamin A deﬁciency (Funegård et al., 1991). In humans, chronic
nutritional deﬁciency in children in India, where Vitamin A deﬁ-
ciency is prevalent, is associated with reduced saliva secretion
(Johansson et al., 1994).
In summary, we have shown that RDH10-mediated metabolism
of Vitamin A generates RA that activates RA signaling within the
developing SMG, and that the RA signaling directly regulates
embryonic growth and morphogenesis of the gland.Acknowledgments
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